Alembic Pharmaceuticals has informed that it enclosed the intimation dated 15th April1 2024 received from Link Intime India Registrar and Share Transfer Agent, regarding approval of the request received for issue of Duplicate Share Certificate(s) and issue of letter of confirmation in lieu of the physical share certificate to the registered shareholder(s) in accordance with the provisions of SEBI Circular No' SEBI/HO/MIRSD/MIRSD RTAMB/P/CIR/2C)22/8 dated 25th January, 2022.
The above information is a part of company’s filings submitted to BSE.
